Olon and Particle Engineering

Olon, a leading international API supplier, is promoting a strong internal focus on the physical form of the API. Today, the chemical quality of the API also involves analyzing and…

Small is Powerful: A Globally Unique Capability for Nanoforming HPAPIs

By Dr. David Rowe – Head of Manufacturing and Antonio da Silva – Senior Director Business Operations, Nanoform In oncology and the wider pharmaceutical market, there is a surge in…

A World of Color: Pigments and Dyes for Capsules

In today’s increasingly visual world, the role that colors play in the success of pharmaceutical and nutraceutical products is likely becoming increasingly important. After all, capsule colors can play a…

What You Need to Know about TiO2-Free Capsules

Titanium dioxide (TiO2) has been such a ubiquitous ingredient in empty capsules that most makers of pharmaceuticals and nutraceuticals probably had not given it much thought… until now. What changed?…

Embracing GMP Manufacturing to Meet Pharma’s Future

The pharma industry is looking to novel technologies for answers to its challenges in all areas of drug development. Such technologies must be able to adhere to GMP for both…

What’s Trending in Hard Capsules for Pharmaceutical Applications?

Why are solid oral dosage formats the most popular formats? Because these delivery systems are the most patient-friendly. They are easy to swallow, easy to transport and do not involve…

Ensuring Business Continuity in Uncertain Times: Understanding Five Risk Categories that Can Lead to Better Mitigation Strategies

In a time where businesses are being forced to come up with contingency plans for pandemics, one industry that is particularly vulnerable is the pharmaceuticals sector. The supply chains that…

Nanomilling ― For Improved Solubility and Bioavailability

A crucial feature of drug development is bioavailability, defined as “the ability of a drug to be absorbed and used by the body.” For a drug to be bioavailable, it…

Small Molecule Orphan Drugs: Balancing Financial Incentives And Complex Challenges

Author: Kevin Kane, Global SME, Thermo Fisher Scientific Abstract:The orphan drug industry focuses on developing life-changing and potentially life-saving treatments for patients living with rare diseases. Previously, the needs of…